Abstract:Background: In the Tumor Microenvironment (TME), hypoxia stands as a significant factor that modulates immune responses, especially those driven by T cells. As T cell-based therapies often fail to work in solid tumors, this study aims to investigate the effects of hypoxia on T cell topo-distribution in the TME, gene expression association with T cell states, and clinical responses in melanoma. Methods: To generate detailed information on tumor oxygenation and T cell accessibility, we utilized mathematical modeling of human melanoma tissue microarrays (TMAs) that incorporate oxygen supply from vessels, intratumoral diffusion, and cellular uptake. We created tumor maps and derived plots showing the fraction of CD4 and CD8 T cells against the distance to the nearest vessel and oxygen pressure. To assess their function and transcriptional changes caused by hypoxia, effector T cells were generated and cultured under hypoxia (0.5% oxygen) or normoxia (21% oxygen). The T cell hypoxia-transcriptional signature was compared against datasets from msigDB, iATLAS (clinical trials of melanoma patients treated with immune checkpoint inhibitors), ORIEN AVATAR (real-world melanoma patients treated with immune checkpoint inhibitors, ICIs), and a single-cell atlas of tumor-infiltrating lymphocytes (TILs). Results: We made three specific observations: 1) in melanoma T cells preferentially accumulated in oxygenated areas close to blood vessels (50-100 micrometers from the vasculature in the regions of high oxygen availability) but not in hypoxic areas far from blood vessels. 2) Our analysis confirmed that under hypoxia, T cell functions were significantly reduced compared to normoxic conditions and accompanied by a unique gene signature. Furthermore, this hypoxic gene signature was prevalent in resting and non-activated T cells. Notably and clinically relevant, the hypoxic T cell gene set was found to correlate with reduced Overall Survival (OS) and reduced progression-free survival (PFS) in melanoma patients, which was more pronounced in non-responder patients undergoing ICI therapy. 3) Finally, compared with a single-cell atlas of tumor-infiltrating T cells, our hypoxia signature aligned with a population of cells at a state termed stress response state (TSTR). Conclusion: Our study highlights the critical role of hypoxia in shaping T cell distribution and its correlation with clinical outcomes in melanoma. We revealed a preferential accumulation of T cells in oxygenated areas. Moreover, hypoxic T cells develop a distinct hypoxic gene signature prevalent in resting, non-activated T cells and TSTR that was also associated with poorer outcomes, particularly pronounced among non-responders to ICIs. ### Competing Interest Statement The authors have declared no competing interest.

Hypoxia: dual effect on the expression of transferrin receptor in human melanoma A375 cell line.

Effector T Cells under Hypoxia Have an Altered Transcriptome Similar to Tumor-Stressed T Cells Found in Non-Responsive Melanoma Patients

Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells.

Targeting Hypoxia-inducible Factor-1|[alpha]| With Tf|[ndash]|PEI|[ndash]|shRNA Complex via Transferrin Receptor|[ndash]|mediated Endocytosis Inhibits Melanoma Growth

Effects of hypoxia on the expressions of hypoxia-inducible factor-1 alpha and miR-210 in hepatocellular carcinoma HepG2 cells

[Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism]

Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma

Determination of Hypoxia Signature to Predict Prognosis and the Tumor Immune Microenvironment in Melanoma

[Effect of Hypoxia on Infiltration and Migration of Lung Cancer Cells and Expression of MMP-2 and TIMP-2].

Identification of Genes Involved in Adaptive Response to Hypoxia and Their Expression Attenuations by Gene Silencing of HIF-1α in A549 Lung Cancer Cells

Hypoxia-based classification and prognostic signature for clinical management of hepatocellular carcinoma

Transferrin, a Cell Pilot and Iron Provider Based on its Interaction with the Overexpressed Transferrin Receptors

Effect of Hypoxia on MMP2,9 and TIMP2,1 in Human Breast Cancer Cell Line

Expressions and Clinical Significance of HIF-1α and Multidrug Resistance Genes in Human Colorectal Adenocarcinoma

Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy

Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells

Effect of hypoxia on expression of MRP1 and the mechanism in human EC9706 cell line

Effect of Hypoxia on Epithelial Growth Factor Receptor Expression and Cell Apoptosis of Breast Cancer and Cervical Cancer Xenografts in Nude Mice

Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers

Effect of Hypoxia on HIF-1α,GLUT-1,and MMP-2 in Human Lung Adenocarcinoma Cells

Hypoxia-inducible factor-1α can reverse the Adriamycin resistance of breast cancer adjuvant chemotherapy by upregulating transferrin receptor and activating ferroptosis